Skip to Primary Navigation

Skip to main content

PMCPA resolves Moderna case regarding tweets, articles about clinical trials

Image of German Health Minister Karl Lauterbach getting vaccinated in Berlin.
Photo: Christian Marquatdt – Pool/Getty Images

Julie DiMauro

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Actions by Moderna and associated third parties caused concern and ‘reflected poorly on the industry’.

The UK’s Prescription Medicines Code of Practice Authority (PMCPA) issued its final resolution in its case against Moderna that pertained to four tweets, two articles and participant information sheets the US pharmaceutical and biosciences company had published online for a Moderna-sponsored clinical trial.

All of the communications referred to the

, , , , , ,